Blood DNA methylation sites predict death risk in a longitudinal study of 12, 300 individuals

Elena Colicino; Riccardo Marioni; Cavin Ward-Caviness; Rahul Gondalia; Weihua Guan; Brian Chen; Pei-Chien Tsai; Tianxiao Huan; Gao Xu; Agha Golareh; Joel Schwartz; Pantel Vokonas; Allan Just; John M. Starr; Allan F. McRae; Naomi R. Wray; Peter M. Visscher; Jan Bressler; Wen Zhang; Toshiko Tanaka; Ann Zenobia Moore; Luke C. Pilling; Guosheng Zhang; James D. Stewart; Yun Li; Lifang Hou; Juan Castillo-Fernandez; Tim Spector; Douglas P. Kiel; Joanne M. Murabito; Chunyu Liu; Mike Mendelson; Tim Assimes; Devin Absher; Phil S. Tsaho; Ake T. Lu; Luigi Ferrucci; Rory Wilson; Melanie Waldenberger; Holger Prokisch; Stefania Bandinelli; Jordana T. Bell; Daniel Levy; Ian J. Deary; Steve Horvath; Jim Pankow; Annette Peters; Eric A. Whitsel; Andrea Baccarelli

doi:doi:10.18632/aging.103408

← Back

Research Paper Volume 12, Issue 14 pp 14092—14124

Blood DNA methylation sites predict death risk in a longitudinal study of 12, 300 individuals

Figure 4. Forest Plots for the association of methylation levels of the FDR-significant fully-adjusted CpGs with risk of future incident coronary heart disease in the CHARGE consortium.